A patent-pending treatment for eosinophilic chronic sinusitis patients who have undergone functional endoscopic sinus surgery and still experience unresolved symptoms.

A patented, single-dose treatment for otitis externa, targeting both bacterial and fungal pathogens, with completed phase 2 proof-of-concept clinical study.